You are here: Home / 404 Not Found Nothing Found Sorry, the post you are looking for is not available. Maybe you want to perform a search? For best search results, mind the following suggestions: Always double check your spelling. Try similar keywords, for example: tablet instead of laptop. Try using more than one keyword. © Astex Pharmaceuticals All rights reserved Useful links Home Sitemap Privacy Policy Terms of Use Legal Member of the Otsuka Group We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok

Clinical Pipeline Clinical Pipeline Pyramid™ Discovery Platform Oncology and CNS Discovery Sustaining Innovation Our partners are advancing several compounds in clinical trials that were the outcome of previous drug discovery collaborations with Astex. The responsibility for developing these products is with our partners. Proprietary Products and Programs Partnered Products and Programs DiscoveryPhase 1Phase 2Phase 3Marketed Kisqali® (ribociclib) CDK4/6 inhibitor (Oncology) Partner: Novartis . . . . . Balversa® (erdafitinib) FGFr inhibitor (Oncology) Partner: Janssen . . . . . AZD5363 (capivasertib) PKB/Akt Inhibitor (Oncology) Partner: AstraZeneca . . . . Multiple Targets and Therapeutic Areas Partner: GlaxoSmithKline . . Partnered products and programs Kisqali® (ribociclib) CDK4/6 inhibitor (Oncology) Partner: Novartis Balversa® (erdafitinib) FGFr inhibitor (Oncology) Partner: Janssen AZD5363 (capivasertib) PKB/Akt Inhibitor (Oncology) Partner: AstraZeneca Multiple Targets and Therapeutic Areas Partner: GlaxoSmithKline © Astex Pharmaceuticals All rights reserved Useful links Home Sitemap Privacy Policy Terms of Use Legal Member of the Otsuka Group We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok